News

Biotech holds steady in January as broader markets head south February 01, 2010 | Press Release

Biotech gets back on track in November December 01, 2009 | Press Release

Biotech takes it on the chin in October November 02, 2009 | Press Release

  See all News
Sign up to receive email notifications about our upcoming events and news.


Submit a Business Plan

Do great things with us.Click here 
Venture Capital
Charles Arntzen—President and CEO Emeritus, Boyce Thompson Institute for Plant Research; Regent’s Professor, Arizona Biodesign Institute, Arizona State University; member of President George W. Bush’s Council of Advisors on Science and Technology (PCAST)

Peter Barton Hutt—Senior Counsel, Covington & Burling, a Washington-based law firm
specializing in food and drug law; former Chief Counsel of the FDA; member of the Institute of
Medicine; teaches Food and Drug Law course at Harvard Law

Nancy Fogg-Johnson—Technology Commercialization Consultant, Technology and Business Ventures; Co-founder of Efficas and NutraGenomics; Former Vice President Biotechnology/ Food Ingredients R&D and Vice President Personal Care Drugs, Bayer; former Vice President, Basic Research, Campbell Soup; former Vice President, R&D and QA, Nabisco Grocery Company

Jordan Gutterman— Distinguished Professor of Medicine, University of Texas, M.D. Anderson
Cancer Center, Houston

Susan Kay Harlander—President, Biorational Consultants; Principal, BTSafety, LLC; former Vice President of Green Giant and Progresso R&D and Agricultural Research at The Pillsbury Company; former Vice President of Biotechnology Development, The Pillsbury Company

Peter Mattson—Founder and Chairman, MATTSON, Largest New Product Development Company in the US Food & Beverage Industry

Charles Muscoplat— Vice President for Statewide Strategic Resource Development; McKnight Presidential Leadership Endowed Chair; Professor of Medicine, Microbiology, Food Science, and Nutrition